[{"AccountsPayableCurrent_0_Q2_USD":8101000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":199000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-310000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":199000.0,"OtherAssetsNoncurrent_0_Q2_USD":18748000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":16396000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":21849000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":20080000.0,"OperatingIncomeLoss_2_Q2_USD":10438000.0,"OperatingIncomeLoss_1_Q2_USD":9180000.0,"NetIncomeLoss_1_Q2_USD":6531000.0,"NetIncomeLoss_2_Q2_USD":9369000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":1863000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-583000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":143000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":1710000.0,"MarketableSecuritiesCurrent_0_Q2_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":363131000.0,"InventoryWriteDown_1_Q2_USD":400000.0,"InventoryWriteDown_2_Q2_USD":2404000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":11818000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":14892000.0,"InventoryNoncurrent_0_Q2_USD":17729000.0,"InventoryNet_0_Q2_USD":42857000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":33876000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":-93000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":-50000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":87084000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q2_USD":112736000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-1608000.0,"IncreaseDecreaseInInventories_2_Q2_USD":6796000.0,"LiabilitiesCurrent_0_Q2_USD":41367000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":2307000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":353000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":0.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":14583000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":14627000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_2_Q2_shares":215000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q2_shares":234000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":640000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q2_USD":0.0,"StockholdersEquity_0_Q2_USD":286804000.0,"ShareBasedCompensation_2_Q2_USD":5056000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":36164000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":17989000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":220000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":38145000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":72437000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":230813000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_2_Q2_USD":352000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":13654000.0,"RepaymentsOfLongTermDebt_2_Q2_USD":0.0,"ProvisionForDoubtfulAccounts_2_Q2_USD":-26000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":49540000.0,"ProductWarrantyAccrual_0_Q2_USD":0.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":643000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":2501000.0,"ProceedsFromIssuanceOfLongTermDebt_2_Q2_USD":0.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":8297000.0,"PreferredStockValue_0_Q2_USD":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":1250000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.01,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":2732000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":7293000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_2_Q2_USD":-1487000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":5347000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-642000.0,"CommonStockSharesIssued_0_Q2_shares":14418000.0,"CommonStockSharesAuthorized_0_Q2_shares":90000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"CommitmentsAndContingencies_0_Q2_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":1364000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":97181000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":97181000.0,"CapitalLeaseObligationsIncurred_2_Q2_USD":220000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":263000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q2_USD":70000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q2_USD":16870000.0,"BusinessCombinationContingentConsiderationLiability_0_Q2_USD":16900000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q2_USD":-13650000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":-18470000.0,"CommonStockSharesOutstanding_0_Q2_shares":14418000.0,"BusinessAcquisitionsProFormaRevenue_2_Q2_USD":72437000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":0.0,"AssetsCurrent_0_Q2_USD":177761000.0,"Assets_0_Q2_USD":363131000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":3900000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":2000000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":1413000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":5056000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":2797000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q2_USD":19000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":60699000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-4852000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":2542000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q2_USD":16396000.0,"AccountsReceivableNetCurrent_0_Q2_USD":29426000.0,"BusinessAcquisitionsProFormaNetIncomeLoss_2_Q2_USD":9369000.0,"CommonStockValue_0_Q2_USD":144000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":6730000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":9059000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":976000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":2599000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":10345000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":9130000.0,"ImpairmentOfIntangibleAssetsFinitelived_2_Q2_USD":0.0,"GrossProfit_2_Q2_USD":41786000.0,"GrossProfit_1_Q2_USD":20812000.0,"GoodwillImpairmentLoss_2_Q2_USD":0.0,"GoodwillImpairmentLoss_1_Q2_USD":0.0,"GoodwillForeignCurrencyTranslationGainLoss_2_Q2_USD":-264000.0,"Goodwill_0_Q2_USD":8149000.0,"GainLossOnSaleOfPropertyPlantEquipment_2_Q2_USD":-831000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":22625000.0,"FinanceLeasePrincipalPayments_2_Q2_USD":147000.0,"FinanceLeaseLiabilityCurrent_0_Q2_USD":1972000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":7754000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_Q2_USD":-59000.0,"ContractWithCustomerLiability_0_Q2_USD":900000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":17333000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":30651000.0,"CostsAndExpenses_1_Q2_USD":11632000.0,"CostsAndExpenses_2_Q2_USD":31348000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":1196000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":14368000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":13100000.0,"EarningsPerShareBasic_1_Q2_USD":0.45,"EarningsPerShareBasic_2_Q2_USD":0.65,"EarningsPerShareDiluted_1_Q2_USD":0.45,"EarningsPerShareDiluted_2_Q2_USD":0.64,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.285,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.094,"DepreciationAndAmortization_2_Q2_USD":7011000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":14393000.0,"Ticker":"ANIK","CIK":"898437","name":"ANIKA THERAPEUTICS, INC.","OfficialName":"Anika Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"337949354.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20210806"}]